GWM
CC icon

Geneos Wealth Management’s Chemours CC Stock Holding History

Geneos Wealth Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19K Sell
864
-1,097
-56% -$19.1K ﹤0.01% 1784
2025
Q4 		$23.1K Buy
1,961
+370
+23% +$4.75K ﹤0.01% 1675
2025
Q3 		$25.2K Sell
1,591
-30
-2% -$435 ﹤0.01% 1638
2025
Q2 		$18.6K Sell
1,621
-645
-28% -$7.27K ﹤0.01% 2063
2025
Q1 		$37.9K Buy
2,266
+1,221
+117% +$20.3K ﹤0.01% 2049
2024
Q4 		$17.7K Sell
1,045
-670
-39% -$13K ﹤0.01% 1790
2024
Q3 		$34.8K Buy
1,715
+274
+19% +$5.6K ﹤0.01% 1335
2024
Q2 		$32.5K Hold
1,441
– – ﹤0.01% 1214
2024
Q1 		$37.8K Sell
1,441
-418
-22% -$11.9K ﹤0.01% 1165
2023
Q4 		$58.6K Buy
1,859
+1,000
+116% +$27.1K ﹤0.01% 1016
2023
Q3 		$24.1K Sell
859
-489
-36% -$16.8K ﹤0.01% 1310
2023
Q2 		$49.7K Sell
1,348
-633
-32% -$19.3K ﹤0.01% 1082
2023
Q1 		$59.3K Sell
1,981
-331
-14% -$10.9K ﹤0.01% 1014
2022
Q4 		$70.8K Sell
2,312
-400
-15% -$12K ﹤0.01% 931
2022
Q3 		$66K Sell
2,712
-546
-17% -$18K ﹤0.01% 932
2022
Q2 		$102K Hold
3,258
– – 0.01% 998
2022
Q1 		$102K Buy
3,258
+89
+3% +$2.78K ﹤0.01% 1084
2021
Q4 		$106K Sell
3,169
-40
-1% -$1.25K ﹤0.01% 1138
2021
Q3 		$96K Buy
3,209
+702
+28% +$22.7K ﹤0.01% 1185
2021
Q2 		$89K Buy
2,507
+897
+56% +$29.7K ﹤0.01% 1206
2021
Q1 		$48K Buy
1,610
+40
+3% +$1.06K ﹤0.01% 1654
2020
Q4 		$43K Sell
1,570
-28
-2% -$666 ﹤0.01% 1529
2020
Q3 		$31K Hold
1,598
– – ﹤0.01% 1452
2020
Q2 		$23K Sell
1,598
-40
-2% -$506 ﹤0.01% 1554
2020
Q1 		$15K Sell
1,638
-582
-26% -$8.39K ﹤0.01% 1622
2019
Q4 		$39K Sell
2,220
-2,630
-54% -$43.7K ﹤0.01% 1383
2019
Q3 		$70K Buy
4,850
+680
+16% +$11.1K ﹤0.01% 1025
2019
Q2 		$100K Buy
4,170
+1,657
+66% +$48.8K 0.01% 908
2019
Q1 		$93K Buy
2,513
+464
+23% +$16.9K 0.01% 888
2018
Q4 		$56K Sell
2,049
-108
-5% -$3.42K ﹤0.01% 1038
2018
Q3 		$85K Sell
2,157
-100
-4% -$4.38K 0.01% 946
2018
Q2 		$100K Sell
2,257
-85
-4% -$4.23K 0.01% 780
2018
Q1 		$114K Buy
2,342
+41
+2% +$2.05K 0.01% 711
2017
Q4 		$115K Sell
2,301
-183
-7% -$9.59K 0.01% 699
2017
Q3 		$125K Sell
2,484
-120
-5% -$5.66K 0.01% 639
2017
Q2 		$98K Buy
2,604
+32
+1% +$1.26K 0.01% 684
2017
Q1 		$99K Buy
2,572
+13
+0.5% +$391 0.01% 661
2016
Q4 		$56K Buy
2,559
+500
+24% +$10.3K 0.01% 798
2016
Q3 		$32K Sell
2,059
-265
-11% -$3.03K ﹤0.01% 958
2016
Q2 		$19K Sell
2,324
-9,448
-80% -$84.2K ﹤0.01% 1127
2016
Q1 		$87K Buy
+11,772
New +$59.2K 0.01% 628

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
WHCM
Wolf Hill Capital Management Greenwich, Connecticut $1.03B AUM 80.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geneos Wealth Management's CC Position: Q1 2026 in Review

Geneos Wealth Management reduced its Chemours (CC) stake by 56% in Q1 2026, selling an estimated $19.1K and leaving 864 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1784.

Geneos Wealth Management first reported a position in CC in Q1 2016 and has held it in 41 quarters since. The position peaked at $125K in Q3 2017. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Geneos Wealth Management held 864 shares of Chemours worth $19K as of Q1 2026.
  • Geneos Wealth Management sold 1,097 Chemours shares in Q1 2026, an estimated $19.1K.
  • Chemours made up ﹤0.01% of Geneos Wealth Management's portfolio in Q1 2026, its #1784 holding.
  • Geneos Wealth Management first reported a position in Chemours in Q1 2016 and has held it in 41 quarters since.
  • Geneos Wealth Management's Chemours position peaked at $125K in Q3 2017.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.